Oral flutamide effects on female acne
Phase 3
- Conditions
- Acne vulgaris.Acne vulgaris
- Registration Number
- IRCT138905044310N3
- Lead Sponsor
- Ardebil medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
1- Female sex
2- Moderate acne
3- Age above 16
4- Having melassma
Exclusion criteria
1- Pregnancy and breastfeeding
2- Hepatic disease
3- Taking OCPs or antiandrogenic drugs
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acne lesion improvment. Timepoint: Every 2 months. Method of measurement: Count of the lesions.
- Secondary Outcome Measures
Name Time Method Side effects of drug. Timepoint: 2 months. Method of measurement: Clinical examination.;Reduction of sebum. Timepoint: 2 months. Method of measurement: Mexameter.;Patient satisfaction. Timepoint: 2 Months. Method of measurement: questionnaire.